Cantor Fitzgerald Boosts UnitedHealth Group (UNH) Price Target to $280.00

UnitedHealth Group (NYSE:UNH) had its target price boosted by Cantor Fitzgerald to $280.00 in a research report sent to investors on Wednesday. The firm currently has an overweight rating on the healthcare conglomerate’s stock. Cantor Fitzgerald also issued estimates for UnitedHealth Group’s FY2019 earnings at $13.80 EPS.

UNH has been the subject of a number of other reports. Goldman Sachs Group initiated coverage on UnitedHealth Group in a research report on Wednesday, January 3rd. They issued a buy rating and a $269.00 target price for the company. Zacks Investment Research downgraded UnitedHealth Group from a buy rating to a hold rating in a research report on Tuesday, September 26th. Morgan Stanley upped their target price on UnitedHealth Group from $215.00 to $235.00 and gave the stock an overweight rating in a research report on Wednesday, October 18th. ValuEngine downgraded UnitedHealth Group from a buy rating to a hold rating in a research report on Thursday, October 5th. Finally, Bank of America upped their target price on UnitedHealth Group from $230.00 to $240.00 and gave the stock a buy rating in a research report on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company. The stock currently has a consensus rating of Buy and a consensus price target of $241.30.

UnitedHealth Group (UNH) traded up $4.73 on Wednesday, reaching $243.16. The company’s stock had a trading volume of 6,233,080 shares, compared to its average volume of 2,990,000. The firm has a market capitalization of $235,100.00, a P/E ratio of 22.70, a price-to-earnings-growth ratio of 1.48 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group has a 12-month low of $156.09 and a 12-month high of $243.90.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.79% and a net margin of 5.25%. The firm’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.11 earnings per share. research analysts predict that UnitedHealth Group will post 11.66 earnings per share for the current fiscal year.

In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Insiders have sold a total of 33,655 shares of company stock valued at $7,469,083 in the last quarter. Insiders own 0.89% of the company’s stock.

A number of large investors have recently made changes to their positions in the business. Oakbrook Investments LLC raised its stake in UnitedHealth Group by 10.1% during the 4th quarter. Oakbrook Investments LLC now owns 46,855 shares of the healthcare conglomerate’s stock valued at $10,330,000 after purchasing an additional 4,305 shares during the period. Mondrian Investment Partners LTD raised its stake in UnitedHealth Group by 0.9% during the 4th quarter. Mondrian Investment Partners LTD now owns 308,817 shares of the healthcare conglomerate’s stock valued at $68,082,000 after purchasing an additional 2,905 shares during the period. Smithbridge Asset Management Inc. DE raised its stake in UnitedHealth Group by 7.5% during the 4th quarter. Smithbridge Asset Management Inc. DE now owns 14,830 shares of the healthcare conglomerate’s stock valued at $3,269,000 after purchasing an additional 1,030 shares during the period. Fox Run Management L.L.C. acquired a new stake in UnitedHealth Group during the 4th quarter valued at $1,019,000. Finally, Sterling Investment Management Inc. raised its stake in UnitedHealth Group by 6.8% during the 4th quarter. Sterling Investment Management Inc. now owns 10,708 shares of the healthcare conglomerate’s stock valued at $2,361,000 after purchasing an additional 679 shares during the period. 86.09% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece was originally published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://transcriptdaily.com/2018/01/19/cantor-fitzgerald-boosts-unitedhealth-group-unh-price-target-to-280-00.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply